Stepan Company reported third-quarter earnings per share of $0.94, exceeding analyst estimates by 21 cents. Revenue also surpassed expectations, reaching $692.15 million against a consensus of $634.3
Stepan Company reported 15% revenue growth to $684.11 million in Q2 2026, beating analyst estimates with an adjusted EPS of $1.18. Analysts upgraded the stock to "Strong Buy" with a price target of $8
Stepan Company exceeded Q2 revenue and earnings estimates, though analysts forecast a loss by 2026 despite higher price targets. The company is projected to grow faster than the broader industry throu
Stepan Company exceeded Q2 2026 expectations with $1.18 EPS and $684.1M revenue, up 15% YoY. Growth was driven by strong organic sales volume and performance in its surfactants division.
Stepan Company reported second-quarter adjusted earnings per share of $1.18, significantly surpassing FactSet estimates of $0.61. This result highlights the company's robust financial performance duri
Stepan Co. beat Q2 earnings and revenue estimates, posting $1.18 per share versus $0.61 expected and $684.11 million in revenue. While shares gained year-to-date, future performance hinges on manageme
Stepan Company reported Q1 2024 earnings with an EPS of $0.64, beating consensus, while revenue declined 15.35% YoY to $551.42 million. Results were announced during an earnings call on April 30, 2024
Stepan Company reported Q1 2026 earnings beating expectations with an EPS of $0.45, driven by volume increases in Crop Productivity and Oilfield segments. Despite Surfactant challenges, the company an
ChemBrief